Prathyusha Duraibabu - 19 Nov 2021 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
Director
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
Issuer symbol
ORGO
Transactions as of
19 Nov 2021
Net transactions value
$0
Form type
4
Filing time
23 Nov 2021, 18:15:03 UTC
Previous filing
14 Jun 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Award $0 +11,340 $0.000000 11,340 19 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over three years beginning November 19, 2021.